tiprankstipranks
Trending News
More News >
Century Therapeutics price target lowered to $5 from $12 at Guggenheim
PremiumThe FlyCentury Therapeutics price target lowered to $5 from $12 at Guggenheim
2M ago
Century Therapeutics Reports 2024 Financial Results and Strategic Updates
Premium
Company Announcements
Century Therapeutics Reports 2024 Financial Results and Strategic Updates
2M ago
Century Therapeutics price target lowered to $2 from $4 at Piper Sandler
Premium
The Fly
Century Therapeutics price target lowered to $2 from $4 at Piper Sandler
2M ago
Century Therapeutics Unveils Advances in Cell Therapies
PremiumCompany AnnouncementsCentury Therapeutics Unveils Advances in Cell Therapies
4M ago
Century Therapeutics price target lowered to $4 from $12 at Piper Sandler
Premium
The Fly
Century Therapeutics price target lowered to $4 from $12 at Piper Sandler
5M ago
Century Therapeutics Faces Termination of BMS Agreement
Premium
Company Announcements
Century Therapeutics Faces Termination of BMS Agreement
5M ago
Century Therapeutics reports Q3 EPS (37c), consensus (45c)
PremiumThe FlyCentury Therapeutics reports Q3 EPS (37c), consensus (45c)
7M ago
Century Therapeutics expects cash to support operations into 2H26
Premium
The Fly
Century Therapeutics expects cash to support operations into 2H26
7M ago
Century Therapeutics sees FY24 GAAP operating expenses $150M-$160M
Premium
The Fly
Century Therapeutics sees FY24 GAAP operating expenses $150M-$160M
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100